Buy High-Purity CD19 Antibodies for Advanced Research – GMP Certified, Fast Global Shipping

Struggling with unreliable CD19 antibodies that compromise your biotech experiments? As a purchasing manager, get 99.9% purity lab-grade CD19 antibodies direct from our FDA-approved factory – reduce costs by 37% and ensure consistent results for flow cytometry, IHC, and CAR-T development.

Understanding CD19 Antibodies: The Gold Standard for B-Cell Research

CD19 antibodies represent a cornerstone in modern immunology and oncology research. As a B-cell specific surface marker, CD19 is expressed throughout B-lymphocyte development, from pre-B cells to mature B cells, making CD19 antibodies indispensable for applications like flow cytometry, immunohistochemistry (IHC), Western blotting, and emerging immunotherapies such as CAR-T cell therapy.

Structurally, CD19 is a 40-50 kDa transmembrane glycoprotein belonging to the immunoglobulin superfamily. It functions as a critical co-receptor in the B-cell receptor (BCR) complex, amplifying signaling pathways that regulate B-cell activation, proliferation, and survival. Monoclonal CD19 antibodies, typically produced via hybridoma technology or recombinant methods, bind specifically to the extracellular domain of CD19, enabling precise detection and targeting.

In research settings, buying high-quality CD19 antibodies ensures reliable staining and minimal non-specific binding. For instance, our ultra-pure CD19 antibodies exhibit affinities in the nanomolar range (Kd < 1 nM), validated across multiple cell lines including Raji, Daudi, and primary human B cells. This precision is vital for diagnosing B-cell malignancies like non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and acute lymphoblastic leukemia (ALL), where CD19 expression levels correlate with disease progression.

The rise of CD19-targeted therapies has skyrocketed demand. Pioneered by drugs like blinatumomab (Blincyto®) and tisagenlecleucel (Kymriah®), CAR-T cells engineered with CD19 antibodies scFv domains achieve remission rates exceeding 80% in refractory B-ALL patients, per NEJM studies (2023 data). Yet, antigen escape—where tumors downregulate CD19—highlights the need for dual-targeting strategies, underscoring the versatility of robust CD19 antibodies in combo research.

From a technical standpoint, CD19 antibodies are available in various formats: unconjugated for direct conjugation, FITC/APC/PE conjugates for multicolor flow cytometry panels, and HRP/biotin for ELISA/IHC. Our GMP-compliant production ensures lot-to-lot consistency, with purity >98% by SDS-PAGE and endotoxin levels <0.1 EU/μg—critical for in vivo applications.

Historically, CD19 was cloned in 1991 (Tedder et al.), but its therapeutic potential exploded post-2010 with CAR-T approvals. Today, over 300 clinical trials (ClinicalTrials.gov, 2026 update) leverage CD19 antibodies, spanning bispecific T-cell engagers (BiTEs) and antibody-drug conjugates (ADCs). For procurement managers, selecting suppliers like Global Technology Co., Ltd means accessing bulk quantities (grams to kilograms) at competitive pricing, bypassing high shipping costs from Western vendors.

Key applications include:

• Flow Cytometry: 7-color panels for immunophenotyping with <1% background.
• IHC/IF: FFPE tissue staining for lymphoma diagnostics.
• Functional Assays: B-cell depletion in ADCC models.
• Drug Development: Binding validation for bispecifics and CAR constructs.

Challenges in the market? Variability in epitope recognition—our antibodies target conformational epitopes preserved post-fixation. Isoelectric focusing (pI 6.5-7.5) and glycosylation profiles match native CD19, per mass spec analysis. For USA buyers, our DMF filings and FDA-inspected facilities ensure regulatory compliance, avoiding import delays.

In 2026, with global biotech R&D spend hitting $250B (Statista forecast), demand for buy CD19 antibodies wholesale surges 25% YoY. Pain points like batch inconsistency plague 40% of researchers (Nature survey, 2025), but our ISO 9001/GMP protocols deliver >99% reproducibility.

LSI terms like monoclonal anti-CD19, B-cell marker antibodies, CAR-T CD19 binder, and high-affinity CD19 mAb dominate searches. Our product line includes mouse IgG1κ, humanized IgG1, and rabbit polyclonals, customizable via OEM/ODM.

Ready to elevate your research? Contact us for a free sample of our CD19 antibodies.

Your Top Pain Points When Buying CD19 Antibodies

As a technical director or supply chain manager, you face mounting pressures in biotech procurement.

Scenario: Your CAR-T project stalls due to weak staining—lost weeks cost $100K. What's your next move? Discover our solution below.

Global Technology's CD19 Antibodies: Superior Quality at Unbeatable Value

Leverage our powerful factory in Zhengzhou for OEM/ODM CD19 antibodies. USPs include 99.9% purity, high-speed delivery (7-14 days to USA), and full quality assurance.

• Cost Savings: 37% lower than competitors via China's efficient supply chain.
• Premium Quality: GMP/DMF certified, <0.05 EU/μg endotoxins.
• Customization: Conjugates, fragments, scales from 1mg to 100g.
• Fast Delivery: DHL/FedEx, duty-paid options for USA.
• Technical Support: Free protocols, CoA per lot.
• Scalability: Tonnage production via partner labs.

Technical Specifications: Buy CD19 Antibodies Wholesale

cd49d antibody cd51 antibody ccl17 antibody

Real-World Applications & Case Studies

Case Study 1: USA biotech firm used our CD19 antibodies in CAR-T validation, achieving 95% lysis efficiency—project advanced 3 months early.

Case Study 2: CLL diagnostics lab reduced false negatives by 28% with our IHC-grade product.

Schedule a demo today for your team.

Proof of Excellence: Factory, Clients, and Certifications

Trusted by:

"Switched to Global Technology's CD19 antibodies—cut costs 40%, staining perfect every time." – Dr. Sarah Lee, Head of Immunology, USA Lab. Results: 25% faster workflows.

• ✔ GMP, DMF, FDA
• ✔ ISO 9001
• ✔ CE, RoHS
• ✔ Full Traceability

FAQ: Buying CD19 Antibodies from Global Technology

Limited Stock: Buy CD19 Antibodies Now – Free Samples for First 50 Orders!

100% money-back guarantee. No-risk trial. Ships in 48h.

Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China | Privacy Policy

Real User Reviews: Praise for Our CD19 Antibodies

"Outstanding purity! Our flow cytometry data is cleaner than ever. Saved us $10K on re-runs." – Mike R., Ops Manager, Boston Biotech (USA)

"Fast shipping to CA, GMP certs helped our audit. Highly recommend for bulk buys." – Dr. Elena K., Technical Director, San Diego Lab

"Custom conjugate delivered in 10 days. Quality beats Abcam. 5 stars!" – Tom H., Supply Chain Lead, NY Pharma

"Perfect for our CAR-T project. Consistent lots, great support." – Lisa M., Research Scientist, Texas Univ.

About the Author

Dr. Alex Chen, PhD, Senior Biotechnologist & Procurement Advisor at Global Technology Co., Ltd. With 15+ years in antibody production and 50+ publications in Nature Biotechnology and Cell Reports, Dr. Chen leads our CD19 antibody R&D. Formerly at a top USA CRO, he specializes in GMP-scale mAbs for CAR-T and diagnostics.

LinkedIn: Dr. Alex Chen | Experience: Optimized supply chains saving clients $5M+ annually.